Regulation of extracellular concentrations of 5-hydroxytryptamine (5- HT)in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 1111-1117

  Knobelman, Deborah A ^a   Kung, Hank F ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; AUTORECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; MALE; MENTAL DISEASE; MICRODIALYSIS; MOUSE; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; AUTORECEPTORS; CORPUS STRIATUM; FENFLURAMINE; FLUOXETINE; MALE; MICE; MICRODIALYSIS; OXADIAZOLES; PIPERAZINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; TETRAHYDRONAPHTHALENES;

EID: 0034010268     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 1A receptors. Pharmacol Biochem Behav 57:301-307.
2. Assie MB and Koek W (1996) Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY 100135, but not WAY 100635, has partial agonist properties. Eur J Pharmacol 304:15-21.
3. Auerbach SB, Rutter JJ and Juliano PJ (1991) Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis. Neuropharmacology 30:307-311.
4. Blier P, de Montigny C and Chaput Y (1987) Modifications of the serotonin system by antidepreseant treatments - Implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:S24-S35.
5. 1B receptor is localized predominantly on axon terminals. Neuroscience 58:167-182.
6. Boschi G, Launay N, Rips R and Scherrmann JM (1995) Brain in vivo microdialysis in the mouse. J Pharmacol Toxicol Methods 33:29-33.
7. 1B knock-out mice. J Neurosci 19:3204-3212.
8. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33:367-386.
9. 1B/ 1D) receptor ligands. Pharmacol Ther 62:385-405.
10. Engel G, Gothert M, Hoyer D, Schlicker E and Hillenbrand H (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332: 1-7.
11. 1A receptor antagonist. Behav Brain Res 73:337-353.
12. Franklin KBJ and Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, Toronto.
13. Hen R (1992) Of mice and flies - Commonalities among 5-HT receptors. Trends Pharmacol Sci 13:160-165.
14. Hjorth S, Bengtsson HJ, Milano S, Lundberg JF and Sharp T (1995) Studies on the role of 5-HT1A autoreceptors and alpha-1 adrenoreceptors in the inhibition of 5-HT release - I. BMY 7378 and prazosin. Neuropharmacology 34:615-620.
15. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat-brain regions as measured by in vivo microdialysis. Life Sci 48:1779-1786.
16. 1B receptor agonist CP 93, 129 suppresses rat hippocampal 5-HT release in vivo - Comparison with RU 24969. Eur J Pharmacol 209:249-252.
17. 1A presynaptic, but not postsynaptic receptor-mediated responses: Relationship to antidepressant-like action. Eur J Pharmacol 138:53-60.
18. Kirby LG, Chou-Green JM, Davis K and Lucki I (1997) The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindolacetic acid. Brain Res 760:218-230.
19. Koe BK, Nielsen JA, Macor JE and Heym J (1992) Biochemical and behavioral studies of the 5-HT1B receptor agonist, CP 94,253. Drug Dev Res 26:241-250.
20. 1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther 280:1268-1279.
21. Kreiss DS, Weiland S and Lucki I (1993) The presence of a 5-HT uptake inhibitor alters pharmacological manipulations of 5-HT release. Neuroscience 52:295-301.
22. 1A sites in rat brain. In vitro binding and autoradiographic studies. J Pharmacol Exp Ther 272:429-437.
23. 1B) agonist that promotes satiety. Psychopharmacology 131:264-270.
24. Maura G, Roccatagliata E and Raiteri M (1986) 5-HT autoreceptors in rat hippocampus:Pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 334:323-326.
25. 11C] WAY-100635 - Explanation of high signal contrast in PET and an aid to biomathematical modelling. Nucl Med Biol 25:215-223.
26. Portas CM Thakkar M, Rainnie D and McCarley RW (1996) Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. J Neurosci 16:2820-2828.
27. Preskorn S (1994) Targeted pharmacotherapy in depression management: Comparative pharmacokinetics of fluoxetine, paroxetine, and sertraline. Int Clin Psychopharmacol 3 (Suppl 9):13-19.
28. Price, GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Gothert M, Jones BJ, Roberts C, Watson JM and Middlemiss DN (1997) SB-216641 and BRL-15572-Compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn-Schmiedeberg's Arch Pharmacol 356:312-320.
29. Rex A, Marsden CA and Fink H (1997) Cortical 5-HT-CCK interactions and anxiety-related behavior of guinea-pigs; a microdialysis study Neurosci Lett 228:79-82.
30. 1B/1D receptor antagonists in dorsal and median raphe innervated brain regions. Eur J Pharmacol 346:175-180.
31. Roberts C, Price GW and Jones BJ (1997) The role of the 5-HT1B/1D receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig. Eur J Pharmacol 326:23-30.
32. Rollema H, Clarke T, Sprouse JS and Schulz DW (1996) Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and 5-HT reuptake inhibitor increases 5-HT release in guinea pig hypothalamus in vivo. J Neurochem 67:2204-2207.
33. Samanin R and Garattini S (1993) Neurochemical mechanism of action of anorectic drugs. Pharmacol Toxicol 73:63-68.
34. Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN and Price GW (1998) SB-224289 - A novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 125:202-208.
35. Sharp T, Bramwell SR and Grahame-Smith DG (1989) 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96:283-290.
36. Skingle M, Beattie DT, Scopes DIC, Starkey SJ, Connor HE, Feniuk W and Tyers MB (1996) GR 127935: A potent and selective 5-HT1D receptor antagonist. Behav Brain Res 73:157-161.
37. Sprouse JS and Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neurons. Neuropharmacology 27:707-715.
38. Trillat A-C, Malagie I, Scearce K, Pons D, Anmella M-C, Jacquot C, Hen R and Gardier AM (1997) Regulation of 5-HT release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: In vivo microdialysis studies. J Neurochem 69:2019-2025.
39. Wong DT, Bymaster FP and Engleman EA (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci 57:411-441.
40. Zhuang ZP, Kung MP, Clarke W, Maayani S, Mu M and Rung HF (1995) Synthesis of R (+) and S (-) trans-8-hydroxy-2-[N-n-propyl-N-(3′-iodo-2′-propenyl)] aminotetralin (trans-8-OH-PIPAT): New 5-HT1A receptor ligands. Chirality 7:452-458.